Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs NextMeds
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · NextMeds: October 2026
vs
Verdict75/ 100
Grade C · #76NextMeds
An online treatment platform advertising time-limited compounded offers and branded prescription routes; ongoing payment terms need confirmation.
Visit NextMedsThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 75/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. NextMeds still earns its place — readers comparing the final quote, commitment and refund policy before paying for a promotional treatment plan.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results75
92
Real-world results75
97Price honesty72
97
Price honesty72
96Prescriber access78
96
Prescriber access78
88Formulary choice60
88
Formulary choice60
95Cancellation fairness84
95
Cancellation fairness84
93Member support82
93
Member support82
Price, coverage & features
| Metric | CoreAge Rx | NextMeds |
|---|---|---|
| Verdict Score | 94/100 | 75/100 |
| Grade | A | C |
| Semaglutide | $99/mo | Not disclosed (ongoing monthly price) |
| Tirzepatide | $149/mo | Not disclosed (ongoing monthly price) |
| Coverage | All 50 states | All 50 states advertised; confirm eligibility |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
NextMeds
What we like
- Lists compounded and branded prescription routes
- Publishes cancellation and refund policies
- Advertises online assessment and delivery
The caveats
- A promotional monthly equivalent does not establish the ongoing flexible monthly price
- Terms and refund policy state different cancellation notice periods
- The refund policy generally treats payment as final, subject to limited conditions
- Confirm which medical provider and pharmacy will deliver care
- Compounded drugs are not FDA-approved
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Readers comparing the final quote, commitment and refund policy before paying for a promotional treatment plan.
Visit NextMeds Read the full NextMeds review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for NextMeds does the reverse.
More on CoreAge Rx
More on NextMeds
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.